Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

USA: The findings from a recent retrospective cohort study involving 3,389 patients with obesity revealed the effectiveness ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

SEMAGLUTIDE. IS THERE BETTER KNOWN AS BRAND NAMES ... THANK YO Children who used the weight loss drug liraglutide in a ...

Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to produce ...

Recent studies suggest a potential link between semaglutide-based medications, such as Ozempic, and an increased risk of ...